14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for VBIV

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.630 6.78 %
R2 0.615 4.19 %
R1 0.605 2.59 %
Current price: 0.590
Support S1 0.575 -2.59 %
S2 0.565 -4.19 %
S3 0.550 -6.78 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.700 18.64 %
R2 0.668 13.25 %
R1 0.660 11.86 %
Current price 0.590
Support S1 0.580 -1.69%
S2 0.576 -2.37%
S3 0.564 -4.41%

VBIV Predictions History

3 years ago
JS predicted that VBIV for 2020-05-11 is going $1.35 (-13.46%)

3 years ago
Alan predicted that VBIV for 2020-05-11 is going $1.31 (-3.68%)

3 years ago
JS predicted that VBIV for 2020-05-08 is going $1.30 (-4.41%)

3 years ago
Jed Esposito predicted that VBIV for 2020-05-08 is going $1.50 (10.29%)

Rank:

4 years ago
JS predicted that VBIV for 2020-05-04 is going $1.13 (-8.13%)

4 years ago
Alan predicted that VBIV for 2020-05-04 is going $1.19 (2.59%)

4 years ago
JS predicted that VBIV for 2020-04-27 is going $1.14 (-6.94%)

4 years ago
Alan predicted that VBIV for 2020-04-27 is going $1.19 (6.25%)

4 years ago
JS predicted that VBIV for 2020-04-22 is going $1.52 (38.18%)

4 years ago
MenaBotrous133210 predicted that VBIV for 2020-04-22 is going

Rank:
Click to get the best stock tips daily for free!

About VBI Vaccines Inc.

VBI Vaccines. VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The company's enveloped virus-like particle (eVLP) platform technology allows for the development of eVLP ... VBIV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT